Switzerland · Delayed Price · Currency is CHF Medacta Group Statistics
Total Valuation
Medacta Group has a market cap or net worth of CHF 3.07 billion. The enterprise value is 3.28 billion.
| Market Cap | 3.07B |
| Enterprise Value | 3.28B |
Important Dates
The last earnings date was Friday, March 13, 2026.
| Earnings Date | Mar 13, 2026 |
| Ex-Dividend Date | May 7, 2026 |
Share Statistics
Medacta Group has 19.91 million shares outstanding. The number of shares has increased by 0.08% in one year.
| Current Share Class | 19.91M |
| Shares Outstanding | 19.91M |
| Shares Change (YoY) | +0.08% |
| Shares Change (QoQ) | +0.17% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 10.82% |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 34.65 and the forward PE ratio is 31.77.
| PE Ratio | 34.65 |
| Forward PE | 31.77 |
| PS Ratio | 4.82 |
| PB Ratio | 7.22 |
| P/TBV Ratio | 7.46 |
| P/FCF Ratio | 111.02 |
| P/OCF Ratio | 21.60 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.46, with an EV/FCF ratio of 118.75.
| EV / Earnings | 36.95 |
| EV / Sales | 5.16 |
| EV / EBITDA | 19.46 |
| EV / EBIT | 30.72 |
| EV / FCF | 118.75 |
Financial Position
The company has a current ratio of 2.08, with a Debt / Equity ratio of 0.58.
| Current Ratio | 2.08 |
| Quick Ratio | 0.77 |
| Debt / Equity | 0.58 |
| Debt / EBITDA | 1.45 |
| Debt / FCF | 8.85 |
| Interest Coverage | 16.86 |
Financial Efficiency
Return on equity (ROE) is 22.83% and return on invested capital (ROIC) is 13.86%.
| Return on Equity (ROE) | 22.83% |
| Return on Assets (ROA) | 8.39% |
| Return on Invested Capital (ROIC) | 13.86% |
| Return on Capital Employed (ROCE) | 16.38% |
| Weighted Average Cost of Capital (WACC) | 9.95% |
| Revenue Per Employee | 312,700 |
| Profits Per Employee | 43,652 |
| Employee Count | 2,036 |
| Asset Turnover | 0.80 |
| Inventory Turnover | 0.89 |
Taxes
In the past 12 months, Medacta Group has paid 18.46 million in taxes.
| Income Tax | 18.46M |
| Effective Tax Rate | 17.20% |
Stock Price Statistics
The stock price has increased by +21.99% in the last 52 weeks. The beta is 1.15, so Medacta Group's price volatility has been higher than the market average.
| Beta (5Y) | 1.15 |
| 52-Week Price Change | +21.99% |
| 50-Day Moving Average | 156.31 |
| 200-Day Moving Average | 150.28 |
| Relative Strength Index (RSI) | 51.14 |
| Average Volume (20 Days) | 17,092 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medacta Group had revenue of CHF 636.66 million and earned 88.88 million in profits. Earnings per share was 4.45.
| Revenue | 636.66M |
| Gross Profit | 427.02M |
| Operating Income | 106.90M |
| Pretax Income | 107.34M |
| Net Income | 88.88M |
| EBITDA | 160.01M |
| EBIT | 106.90M |
| Earnings Per Share (EPS) | 4.45 |
Balance Sheet
The company has 30.92 million in cash and 244.64 million in debt, with a net cash position of -213.72 million or -10.73 per share.
| Cash & Cash Equivalents | 30.92M |
| Total Debt | 244.64M |
| Net Cash | -213.72M |
| Net Cash Per Share | -10.73 |
| Equity (Book Value) | 425.08M |
| Book Value Per Share | 21.35 |
| Working Capital | 217.23M |
Cash Flow
In the last 12 months, operating cash flow was 142.12 million and capital expenditures -114.47 million, giving a free cash flow of 27.66 million.
| Operating Cash Flow | 142.12M |
| Capital Expenditures | -114.47M |
| Depreciation & Amortization | 52.55M |
| Net Borrowing | 1.90M |
| Free Cash Flow | 27.66M |
| FCF Per Share | 1.39 |
Margins
Gross margin is 67.07%, with operating and profit margins of 16.79% and 13.96%.
| Gross Margin | 67.07% |
| Operating Margin | 16.79% |
| Pretax Margin | 16.86% |
| Profit Margin | 13.96% |
| EBITDA Margin | 25.13% |
| EBIT Margin | 16.79% |
| FCF Margin | 4.34% |
Dividends & Yields
This stock pays an annual dividend of 1.10, which amounts to a dividend yield of 0.71%.
| Dividend Per Share | 1.10 |
| Dividend Yield | 0.71% |
| Dividend Growth (YoY) | 25.45% |
| Years of Dividend Growth | 4 |
| Payout Ratio | 15.36% |
| Buyback Yield | -0.08% |
| Shareholder Yield | 0.65% |
| Earnings Yield | 2.89% |
| FCF Yield | 0.90% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Medacta Group has an Altman Z-Score of 5.95 and a Piotroski F-Score of 5.
| Altman Z-Score | 5.95 |
| Piotroski F-Score | 5 |